These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27134658)

  • 21. A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.
    Cohen NA; Livovsky DM; Yaakobovitch S; Ben Yehoyada M; Ben Ami R; Adler A; Guzner-Gur H; Goldin E; Santo ME; Halpern Z; Paz K; Maharshak N
    Isr Med Assoc J; 2016 Oct; 18(10):594-599. PubMed ID: 28471618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection.
    Zhang K; Beckett P; Abouanaser S; Stankus V; Lee C; Smieja M
    BMC Infect Dis; 2019 Jan; 19(1):51. PubMed ID: 30642269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal Microbiota Transplantation for Clostridium difficile Infection: The Ochsner Experience.
    Ray A; Smith R; Breaux J
    Ochsner J; 2014; 14(4):538-44. PubMed ID: 25598718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
    Tan X; Johnson S
    Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal microbiota transplantation in refractory or recurrent Clostridium difficile infection: a real-life experience in a non-academic center.
    Ponte A; Pinho R; Mota M; Silva J; Vieira N; Oliveira R; Rodrigues J; Sousa M; Sousa I; Carvalho J
    Rev Esp Enferm Dig; 2018 May; 110(5):311-315. PubMed ID: 29411989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current challenges in the treatment of severe
    van Beurden YH; Nieuwdorp M; van de Berg PJEJ; Mulder CJJ; Goorhuis A
    Therap Adv Gastroenterol; 2017 Apr; 10(4):373-381. PubMed ID: 28491142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment.
    Allegretti JR; Allegretti AS; Phelps E; Xu H; Kassam Z; Fischer M
    Clin Microbiol Infect; 2018 Jul; 24(7):780.e1-780.e3. PubMed ID: 29104169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review.
    Chapman BC; Moore HB; Overbey DM; Morton AP; Harnke B; Gerich ME; Vogel JD
    J Trauma Acute Care Surg; 2016 Oct; 81(4):756-64. PubMed ID: 27648772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.
    Drekonja D; Reich J; Gezahegn S; Greer N; Shaukat A; MacDonald R; Rutks I; Wilt TJ
    Ann Intern Med; 2015 May; 162(9):630-8. PubMed ID: 25938992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
    Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five years of fecal microbiota transplantation - an update of the Israeli experience.
    Greenberg SA; Youngster I; Cohen NA; Livovsky DM; Strahilevitz J; Israeli E; Melzer E; Paz K; Fliss-Isakov N; Maharshak N
    World J Gastroenterol; 2018 Dec; 24(47):5403-5414. PubMed ID: 30598584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
    Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
    Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?
    Allegretti JR; Kassam Z; Chan WW
    Dig Dis Sci; 2018 Jan; 63(1):193-197. PubMed ID: 29188472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients.
    Di Bella S; Gouliouris T; Petrosillo N
    J Infect Chemother; 2015 Apr; 21(4):230-7. PubMed ID: 25703532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of fecal microbiota transplant in 9 critically ill patients with severe and complicated Clostridium difficile infection with impending colectomy.
    Alukal J; Dutta SK; Surapaneni BK; Le M; Tabbaa O; Phillips L; Mattar MC
    J Dig Dis; 2019 Jun; 20(6):301-307. PubMed ID: 30969003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent
    van Beurden YH; de Groot PF; van Nood E; Nieuwdorp M; Keller JJ; Goorhuis A
    United European Gastroenterol J; 2017 Oct; 5(6):868-879. PubMed ID: 29026601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zinc Deficiency and the Recurrence of
    Niccum BA; Stein DJ; Behm BW; Hays RA
    J Nutr Metab; 2018; 2018():9682975. PubMed ID: 30405910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI).
    Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL
    Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review.
    Iqbal U; Anwar H; Karim MA
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):730-734. PubMed ID: 29688901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections.
    Jamot S; Raghunathan V; Patel K; Kelly CR; Lim SH
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):302-306. PubMed ID: 29363436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.